Kyorin Pharmaceutical Co.,ltd. (4569) Press Release
KYORIN to Commence Promotion Activities for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
Earlier from Kyorin Pharmaceutical Co.,ltd
- [Summary]Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]
- KYORIN Entered into Joint Marketing Agreement in Japan for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
- KYORIN Pharmaceutical: Operating profit fell 71.6% year-over-year as sales declined and R&D costs rose
- Kyorin Pharmaceutical Co Ltd - Kyorin Enters Into License Agreement With Biodol For Novel Neuropathic Pain Treatment